Table 6 |
||||||
|
Transmission disequilibrium test for TLR1–TLR6 haplotypes (rs5743618–rs5743594–rs5743810) |
||||||
|
Overall population |
RF-positive patients |
Anti-CCP-positive patients |
||||
|
|
|
|
||||
|
Haplotype (frequency >5%) |
Transmitted/untransmitted |
P value |
Transmitted/untransmitted |
P value |
Transmitted/untransmitted |
P value |
|
|
||||||
|
GCC |
16/12 |
0.45 |
13/8 |
0.28 |
12/9 |
0.51 |
|
GCT |
28/31 |
0.7 |
21/27 |
0.39 |
22/26 |
0.56 |
|
GTC |
12/11 |
0.83 |
10/7 |
0.47 |
9/7 |
0.62 |
|
TCC |
20/21 |
0.88 |
18/20 |
0.75 |
18/19 |
0.87 |
|
|
||||||
|
Linkage disequilibrium: TLR1_SNP1 (rs5743618) – TLR1_SNP2 (rs5743594), D' = 0.94; TLR1_SNP2 (rs5743594) – TLR6_SNP1 (rs5743810), D' = 0.5. RF, rheumatoid factor; anti-CCP, anti-cyclic citrullinated peptide. |
||||||
|
Jaen et al. Arthritis Research & Therapy 2009 11:R5 doi:10.1186/ar2589 |
||||||